Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation

Paris Brain Institute

is a leading scientific and medical research center dedicated to the study of the brain and the discovery of new treatments for diseases of the nervous system. 

Learn more
Scroll

Event Brain Week: three conferences on the agenda

The Brain Institute is participating in three conferences organized as part of Brain Week, the international event dedicated to neuroscience, held from March 16 to 22, 2026.

More information (in French)
Semaine du Cerveau : trois conférences au programme

Video Neurofocus: the CaCovi Project on Epilepsy and Schizophrenia

Discover the CaCovi project, which has shown that brain activity is regulated by inhibitory neurons called "basket cells", endowed with receptors sensitive to endogenous cannabinoids, opening up therapeutic prospects for pathologies such as epilepsy, schizophrenia and anxiety.

Watch the video
Projet CaCovi

Our latest news

Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Summer School 2026 « Modeling Human Neuropathologies » : les inscriptions sont ouvertes
Registration is open for Summer School 2026: “Modeling Human Neuropathologies”
Paris Brain Institute is co-organizing the 3rd edition of the “Modeling Human Neuropathologies” Summer School, together with the Interdisciplinary Center for Neurosciences (University of Heidelberg). The summer school is an intensive international...
03.04.2026 Teaching & training
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Cerveau modélisé
Paris Brain Institute Call for Junior Group Leaders in Artificial Intelligence and Data Science
The Paris Brain Institute is launching a Call for Junior Group Leaders, inviting outstanding early-career scientists in artificial intelligence, data science, computational neuroscience, and related fields to establish their own independent research...
02.11.2026 Institutional
Portrait Violetta Zujovic
Violetta Zujovic: championing women and girls in science
Violetta Zujovic is team leader and scientific manager of the facility. Her research focuses on the immune system’s role in myelin repair, which is a key factor in neurological disorders such as multiple sclerosis and certain leukodystrophies. With...
03.04.2026 Portraits
See all our news
Des mains de chercheuse qui manipulent

Research at Paris Brain Institute

Since its creation, Paris Brain Institute has placed patients at the heart of its scientific and medical strategy.

  • 878 Staff

    including 84% scientific, medical and paramedical staff (as at September 30, 2024)

  • 29 Research teams

    selected by a Scientific Advisory Board

  • 51 Nationalities

    (as at September 30, 2024)

  • 12 Technical facilities

    and biobank

Find out more

Understanding the brain

Le fonctionnement du cerveau : deux scientifiques regardent des images de cerveau
Understanding the Brain
Every day, scientific research tells us a little more about the brain, the body’s control room for all cognition, memory and emotions. From the anatomy of the brain to the latest knowledge about consciousness and the different neurological diseases...
Imagerie cérébrale Lubetzki Stankoff
Alzheimer's disease
With longer life expectancies and the biological mechanisms at the origin of neurodegenerative diseases becoming increasingly complex, it is now estimated that, in France in 2020, 1.3 million people were affected by Alzheimer’s disease. Today, more...
Imagerie cérébrale Corti Corvol Parkinson
Parkinson's disease
Parkinson’s disease is the second-most common neurodegenerative condition after Alzheimer’s disease, and the main cause of Parkinsonian syndrome.
Imagerie scientifique équipe Boilée
Lou Gerhig’s disease or amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS), or ‘Lou Gerhig’s disease’, is a progressive and fatal neuromuscular condition involving the gradual death of motor neurons, the neurons that control walking, speech, swallowing and breathing. This loss of motor...
Imagerie médicale Baulac
Epilepsy
The word ‘epilepsy’ originates from a Greek word meaning ‘to seize’, reflecting the sudden and unpredictable onset of seizures. In France, 600,000 people are affected by this chronic neurological disease, which can present with different symptoms...
Visages bleus
Depression
Mental health, an essential component of our overall health, is a state of well-being, and an ability of the mind to function normally and respond appropriately to environmental stimuli. Mental disorders occur when this state of well-being is...

How support Paris Brain Institute?

And commit to it